Diagnostica Stago R&D clinical trials
A subsidiary of Stago
The registry lists 5 studies whose lead sponsor is Diagnostica Stago R&D. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 26, 2025.
Registry sponsor names on this page
- Diagnostica Stago R&D5 studies
Something wrong with this grouping? Tell us on the Stago page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Stago studies →
- Exclusion of Venous Thrombo-Embolism With a New Clinical Decision SupportRecruitingNCT06480994
Sponsor listed in the registry: Diagnostica Stago R&D
- Determination of Fibrin Activity in Plasma on STA-R® PrototypeCompletedNCT02856789
Sponsor listed in the registry: Diagnostica Stago R&D
- Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWHCompletedNCT02552381
Sponsor listed in the registry: Diagnostica Stago R&D
- Soluble Fibrin for Diagnosing Pulmonary EmbolismCompletedNCT02438462
Sponsor listed in the registry: Diagnostica Stago R&D
- Evaluation of Soluble Fibrin in Thrombosis ExclusionCompletedNCT02523937
Sponsor listed in the registry: Diagnostica Stago R&D